Microfluidics Market Size to Hit USD 110.40 Billion By 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Microfluidics Market, By Material

7.1. Microfluidics Market, by Material Type
7.1.1. Glass
7.1.1.1. Market Revenue and Forecast
7.1.2. Silicon
7.1.2.1. Market Revenue and Forecast
7.1.3. PDMS
7.1.3.1. Market Revenue and Forecast
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast
7.1.5. Others
7.1.5.1. Market Revenue and Forecast

Chapter 8. Global Microfluidics Market, By Application

8.1. Microfluidics Market, by Application
8.1.1. Organs-on-chips
8.1.1.1. Market Revenue and Forecast
8.1.2. Lab-on-a-chip
8.1.2.1. Market Revenue and Forecast
8.1.3. Continuous Flow Microfluidics
8.1.3.1. Market Revenue and Forecast
8.1.4. Acoustofluidics and Microfluidics
8.1.4.1. Market Revenue and Forecast
8.1.5. Optofluidics and Microfluidics
8.1.5.1. Market Revenue and Forecast
8.1.6. Electrophoresis and Microfluidics
8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Microfluidics Market, By Technology

9.1. Microfluidics Market, by Technology
9.1.1. Non-Medical
9.1.1.1. Market Revenue and Forecast
9.1.2. Medical (Gel Electrophoresis, PCR & RT-PCR, ELISA, Microarrays, Others)
9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Microfluidics Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Material
10.1.2. Market Revenue and Forecast, by Application
10.1.3. Market Revenue and Forecast, by Technology
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material
10.1.4.2. Market Revenue and Forecast, by Application
10.1.4.3. Market Revenue and Forecast, by Technology
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material
10.1.5.2. Market Revenue and Forecast, by Application
10.1.5.3. Market Revenue and Forecast, by Technology
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material
10.2.2. Market Revenue and Forecast, by Application
10.2.3. Market Revenue and Forecast, by Technology
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material
10.2.4.2. Market Revenue and Forecast, by Application
10.2.4.3. Market Revenue and Forecast, by Technology
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material
10.2.5.2. Market Revenue and Forecast, by Application
10.2.5.3. Market Revenue and Forecast, by Technology
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material
10.2.6.2. Market Revenue and Forecast, by Application
10.2.6.3. Market Revenue and Forecast, by Technology
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material
10.2.7.2. Market Revenue and Forecast, by Application
10.2.7.3. Market Revenue and Forecast, by Technology
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material
10.3.2. Market Revenue and Forecast, by Application
10.3.3. Market Revenue and Forecast, by Technology
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material
10.3.4.2. Market Revenue and Forecast, by Application
10.3.4.3. Market Revenue and Forecast, by Technology
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material
10.3.5.2. Market Revenue and Forecast, by Application
10.3.5.3. Market Revenue and Forecast, by Technology
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material
10.3.6.2. Market Revenue and Forecast, by Application
10.3.6.3. Market Revenue and Forecast, by Technology
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material
10.3.7.2. Market Revenue and Forecast, by Application
10.3.7.3. Market Revenue and Forecast, by Technology
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material
10.4.2. Market Revenue and Forecast, by Application
10.4.3. Market Revenue and Forecast, by Technology
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material
10.4.4.2. Market Revenue and Forecast, by Application
10.4.4.3. Market Revenue and Forecast, by Technology
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material
10.4.5.2. Market Revenue and Forecast, by Application
10.4.5.3. Market Revenue and Forecast, by Technology
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material
10.4.6.2. Market Revenue and Forecast, by Application
10.4.6.3. Market Revenue and Forecast, by Technology
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material
10.4.7.2. Market Revenue and Forecast, by Application
10.4.7.3. Market Revenue and Forecast, by Technology
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Market Revenue and Forecast, by Technology
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material
10.5.4.2. Market Revenue and Forecast, by Application
10.5.4.3. Market Revenue and Forecast, by Technology
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material
10.5.5.2. Market Revenue and Forecast, by Application
10.5.5.3. Market Revenue and Forecast, by Technology

Chapter 11. Company Profiles

11.1. Agilent Technologies, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Perkinelmer, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Life Technologies Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott Laboratories
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Qiagen N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Thermo Fischer Scientific
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Biomérieux
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Cellix Ltd.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Elveflow
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Micronit Micro Technologies B.V.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The microfluidics market size is valued at USD 30.66 billion in 2025 and is predicted to hit around USD 110.40 billion by 2034.

Answer : The microfluidics market grow is anticipated to grow at a CAGR of 15.30% from 2025 to 2034.

Answer : Rising demand for Point of Care (POC) testing in a wide range of applications because of the benefits associated with the incorporation of microfluidics along with high return on investments anticipated to propel the market growth of microfluidics during the analysis period. In addition, high-throughput screening methodologies, low-volume sample analysis, and increased demand for in vitro diagnostics (IVD) expected to offer numerous growth opportunities for the players operating in the microfluidics market during the forthcoming years.

Answer : The lab-on-a-chip application accounted for the largest value share in the global market and estimated to continue its dominance throughout the analysis period.

Answer : The major players in the microfluidics market include Agilent Technologies, Inc., Illumina, Inc., Perkinelmer, Inc., Life Technologies Corporation, Danaher, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, Abbott Laboratories, Fluidigm Corporation, Qiagen N.V., Thermo Fischer Scientific, BiomÃ©rieux, Cellix Ltd, Elveflow and Micronit Micro Technologies B.V.